Knee Osteoarthritis Treatment With Adipose-derived Stem Cells: Phase II Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 30, 2018

Study Completion Date

April 12, 2023

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

Stem cells

Participants will be exposed to e abdominal liposuction procedure under local anesthesia for stem cells harvesting. Stem cells will be separated from fat cells in the adipose tissue then activated in Tissue Culture Lab at Research Center- Jeddah. The activated stem cells will be injected into the knee joint via 22G spinal needle. The intra-articular stem cells injections will be performed under Ultrasound guidance at the theater under spinal anesthesia. Each patient will receive 1.0× 108 stem cells in 3 mL of normal saline.

Trial Locations (1)

Unknown

King Faisal Sepcialist Hospital and Research Center, Jeddah

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT03308006 - Knee Osteoarthritis Treatment With Adipose-derived Stem Cells: Phase II Clinical Trial | Biotech Hunter | Biotech Hunter